Medicis Pharmaceutical 10-Q 2005 Q1 Quarterly report

Exhibit 12

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(in thousands)

																Nine Months
																Ended
	Fiscal Year Ended June 30,															Mar. 31,
	2000			2001			2002			2003			2004			2005
EARNINGS:
Income before income tax expense	$	67,382		$	59,325		$	78,984		$	77,660		$	46,157		$	61,716
Add: Fixed charges		3,378			2,801			2,967			14,375			13,161			9,711
Earnings as defined	$	70,760		$	62,126		$	81,951		$	92,035		$	59,318		$	71,427
FIXED CHARGES:
Interest expense	$	2,246		$	1,263		$	1,376		$	10,038		$	8,663		$	6,366
Amortization of deferred financing fees		—			—			—			2,542			2,145			1,616
Interest expense as reported		2,246			1,263			1,376			12,580			10,808			7,982
Portion of rent expense as interest		1,132			1,538			1,591			1,795			2,353			1,729
Fixed charges as defined	$	3,378		$	2,801		$	2,967		$	14,375		$	13,161		$	9,711
Ratio of earnings to fixed charges		21.0	x		22.2	x		27.6	x		6.4	x		4.5	x		7.4	x

For purposes of computing the ratios of earnings to fixed charges, earnings represent pretax income from continuing operations plus fixed charges. Fixed charges represent interest expense and the portion of rents representative of interest related to continuing operations.